After interviewing Robert Sapolsky, a professor of biology, neurosciences, neurology and neurobiological sciences, and neurosurgery at Stanford University, I've been looking into medications that are currently on the market for treating Alzheimer's disease. Today the most commonly used drugs (that have been approved by the Food and Drug Administration) for treating the illness are: Razadyne, Exelon, and Aricept, Cognex. Cognex, however, is rarely proscribed today for safety reasons.
I still can't believe how few drugs are available for the millions with Alzheimer's disease!
Furthermore, although such medications may delay an eventual worsening of the disease, we still haven't found a cure. Where are the drugs that actually reverse or prevent the illness's onset?
Perhaps the public will have to turn to other options of facing this deadly illness. Sapolsky concurs that denial is a common reaction to the current lack of treatment. He believes that "denial could be [beneficial] because there are just a handful of drugs" with minimal effects on the market. I definitely believe he has a valid point.
Nov 21, 2009
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment